
MindWalk's 660M-Pattern Biology Map Draws Pharma as Novo Nordisk Outsources R&D and Stock Jumps 25%
MindWalk Holdings filed a new patent extending its HYFT biology-representation technology, built on roughly 660 million biological patterns, as NVIDIA anchors AI drug-discovery partnerships with Thermo Fisher and Eli Lilly. Novo Nordisk closed its internal cell therapy unit and licensed the program to Cellular Intelligence instead of building in-house, and its shares rallied nearly 25% in 30 days.


